Skip to main content
Harvey Mamon, MD, Radiation Oncology, Boston, MA, Dana-Farber Cancer Institute

HarveyJayMamonMD

Radiation Oncology Boston, MA

Gastrointestinal Cancer

Associate Professor of Radiation Oncology, Brigham and Women's Hospital

Dr. Mamon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mamon's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Joint Center for Radiation Therapy
    Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1994 - 1998
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1993 - 1994
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 1993

Certifications & Licensure

  • ME State Medical License
    ME State Medical License 2020 - 2025
  • MA State Medical License
    MA State Medical License 1998 - 2025
  • CT State Medical License
    CT State Medical License 2022 - 2024
  • NH State Medical License
    NH State Medical License 2022 - 2024
  • RI State Medical License
    RI State Medical License 2022 - 2024
  • FL State Medical License
    FL State Medical License 2022 - 2024
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer  
    Harvey J Mamon, Paul L Nguyen, Theodore S Hong, Aparna Parikh, Jennifer Y Wo, Rinaa S Punglia, Cristina Ferrone, Ryan D Nipp, Annals of Surgical Oncology

Press Mentions

  • Phase 3 Studies for Rectal, Brain, and Kidney Cancers to Be Presented by Dana-Farber Researchers at ASCO 2023
    Phase 3 Studies for Rectal, Brain, and Kidney Cancers to Be Presented by Dana-Farber Researchers at ASCO 2023May 26th, 2023
  • For Some Cancers, Less Treatment Is a Better Bet
    For Some Cancers, Less Treatment Is a Better BetJune 6th, 2023
  • PROSPECT Trial Expands Treatment Options for Patients with Resectable Rectal Cancer
    PROSPECT Trial Expands Treatment Options for Patients with Resectable Rectal CancerJune 8th, 2023
  • Join now to see all

Professional Memberships

Hospital Affiliations